HINJ Applauds Enactment of FDA User Fee Reauthorization Law
New Brunswick, NJ, July 10, 2012 ― The HealthCare Institute of New Jersey (HINJ) applauds the enactment of the Food and Drug Administration Safety and
New Brunswick, NJ, July 10, 2012 ― The HealthCare Institute of New Jersey (HINJ) applauds the enactment of the Food and Drug Administration Safety and
New Brunswick, NJ, June 28, 2012 ― The HealthCare Institute of New Jersey (HINJ) has issued the following statement regarding the ruling today by the
New Brunswick, NJ, June 1, 2012 ― The HealthCare Institute of New Jersey (HINJ) applauds the overwhelming, bipartisan approval by the United States Senate and
New Brunswick, May 18, 2012―Appearing on New Jersey Capitol Report with anchors Steve Adubato and Rafael Pi Roman, HealthCare Institute of New Jersey (HINJ) President
New Brunswick, NJ, May 15, 2012 ― The HealthCare Institute of New Jersey (HINJ) has appointed Douglas Berger as its Director of Communications. In this
New Brunswick, NJ, January 4, 2012 — The HealthCare Institute of New Jersey (HINJ) today released key findings of its 2011 economic impact survey, which
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
HealthCare Institute of New Jersey (HINJ)
222 W. State Street
Suite 302
Trenton, NJ 08608
Phone: 732-729-9619
©2023. HealthCare Institute of New Jersey (HINJ). All rights reserved.